Characteristics | VATS group (n = 167) | OT group (n = 124) | P |
---|---|---|---|
Age, years | 58.37 ± 11.06 | 60.02 ± 10.91 | 0.204 |
Sex (Male/Female) | 98/69 | 84/40 | 0.142 |
History of smoking (%) | 57 (34.1) | 50 (40.3) | 0.326 |
Charlson scores | 0 (1) | 0 (0) | 0.127 |
Tumor location (%) | 0.303 | ||
LUL | 49 (29.3) | 37 (29.8) | |
LLL | 34 (20.4) | 15 (12.1) | |
RUL | 41 (24.6) | 37 (29.8) | |
RML | 6 (3.6) | 8 (6.5) | |
RLL | 37 (22.2) | 27 (21.8) | |
Operative time (h) | 3.10 (1.50) | 2.55 (1.00) | < 0.001 |
No. of LND | |||
Stage I | 13.5 (14) | 17.5 (13) | 0.142 |
Stage II | 15 (13) | 25.5 (15) | < 0.001 |
Stage IIIA | 26 (12) | 37 (10) | < 0.001 |
No. of station of LND | |||
Stage I | 7 (2) | 7 (3) | 0.281 |
Stage II | 6 (2) | 7 (1) | < 0.001 |
Stage IIIA | 6 (2) | 7 (3) | 0.003 |
Histology (%) | 0.417 | ||
Squamous cell carcinoma | 43 (25.7) | 40 (32.3) | |
Adenicarcinoma | 104 (62.3) | 67 (54.0) | |
Others | 20 (12.0) | 17 (13.7) | |
Chest tube duration (d) | 4(1) | 5 (2) | 0.007 |
Pathological stage (%) | 0.160 | ||
I | 118 (70.7) | 84 (67.7) | |
II | 34 (20.4) | 20 (16.1) | |
IIIA | 15 (9.0) | 20 (16.1) | |
Morbidity (%) | 5 (3.0) | 6 (4.8) | 0.537 |
Mortality (%) | 1 (0.6) | 0 (0) | 0.431 |
Hospital LOS (d) | 15 (5) | 17 (5) | < 0.001 |
Postoperative LOS (d) | 9 (3) | 10.5 (3) | < 0.001 |
VATS, video assisted thoracic surgery; OT, open thoracotomy; LUL, left upper lobe; LLL, left lower lobe; RUL, right upper lobe; RML, right middle lobe; RLL, right lower lobe; LND, lymph node dissection; LOS, length of stay.